Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Laura Huppert MD

Laura A. Huppert MD

Assistant Professor of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California

Dr. Laura Huppert is an Assistant Professor and breast medical oncologist at the University of California, San Francisco (UCSF). Dr. Huppert earned her medical degree at Harvard Medical School. She completed Internal Medicine Residency and Hematology/Oncology Fellowship at UCSF before starting on faculty at UCSF in 2022. Dr. Huppert is interested in clinical and translational breast cancer research in both early-stage and metastatic disease. She is involved in the I-SPY2 clinical trial for neoadjuvant therapy in early-stage breast cancer. She is also interested in designing clinical trials with novel therapies for patients with metastatic breast cancer, including better evaluation and management of toxicities. She has received an ASCO Merit Award and is currently the recipient of the Helen Diller Comprehensive Cancer Center K12 Physician Scientist Program in Clinical Oncology.


Dr. Huppert reports the following:
  • Ad board: AstraZeneca, Pfizer
  • Book honorarium: McGraw Hill